Regeneron Pharmaceuticals Inc (NASDAQ:REGN)
| 801.15 Delayed Data As of Nov 28 |  +3.07 / +0.38%Today’s Change | 668.00 Today|||52-Week Range 853.97 | +11.04% Year-to-Date |
Latest REGN News | Press Releases
| Regeneron (REGN), Sanofi's Dupixent Succeeds in 2nd COPD Study Nov 27 / Zacks.com - Paid Partner Content | HRMY vs. REGN: Which Stock Is the Better Value Option? Nov 21 / Zacks.com - Paid Partner Content |
| Kiniksa Pharmaceuticals (KNSA) Up 14.7% YTD: Here's How Nov 24 / Zacks.com - Paid Partner Content | Should You Invest in the iShares Biotechnology ETF (IBB)? Nov 20 / Zacks.com - Paid Partner Content |
| Regeneron (REGN) Stock Rallies 10% YTD: What Lies Ahead? Nov 24 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 798.08 |
| Today’s open | 795.96 |
| Day’s range | 792.43 - 801.61 |
| Volume | 18,223 |
| Average volume (3 months) | 462,331 |
| Market cap | $87.0B |
Data as of 3:59pm ET, 11/28/2023
Growth & Valuation
| Earnings growth (last year) | -46.98% |
| Earnings growth (this year) | -9.37% |
| Earnings growth (next 5 years) | +2.38% |
| Revenue growth (last year) | -24.26% |
| P/E ratio | 22.9 |
| Price/Sales | 6.73 |
| Price/Book | 3.86 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| VRTXVertex Pharmaceutica... | -3.25 | -0.93% |
| ZTSZoetis Inc | -1.81 | -1.01% |
| ---- | ||
| BMYBristol-Myers Squibb | -0.10 | -0.20% |
Data as of 4:00pm ET, 11/28/2023
Financials
| Next reporting date | February 8, 2024 |
| EPS forecast (this quarter) | $10.21 |
| Annual revenue (last year) | $12.2B |
| Annual profit (last year) | $4.3B |
| Net profit margin | 35.64% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Tarrytown, New York |
Forecasts
